Pinnbrook Capital Management LP Makes New Investment in Danaher Corporation $DHR

Pinnbrook Capital Management LP purchased a new stake in Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 23,734 shares of the conglomerate’s stock, valued at approximately $17,089,000. Danaher comprises 1.8% of Pinnbrook Capital Management LP’s investment portfolio, making the stock its 13th biggest holding.

Other institutional investors have also made changes to their positions in the company. Main Street Group LTD bought a new stake in Danaher during the 1st quarter valued at approximately $25,000. N.E.W. Advisory Services LLC acquired a new stake in Danaher in the 2nd quarter valued at approximately $25,000. JPL Wealth Management LLC bought a new position in Danaher in the 3rd quarter worth approximately $25,000. WFA of San Diego LLC acquired a new position in shares of Danaher during the second quarter worth approximately $26,000. Finally, Hilton Head Capital Partners LLC acquired a new position in shares of Danaher during the fourth quarter worth approximately $27,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Trading Up 1.6%

Shares of DHR stock opened at $219.42 on Friday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The firm has a 50-day moving average price of $195.80 and a 200 day moving average price of $192.61.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same quarter last year, the business posted $0.77 earnings per share. The company’s revenue was up 5.5% on a year-over-year basis. Research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on DHR shares. Citigroup initiated coverage on shares of Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective on the stock. Wolfe Research cut shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. TD Cowen reduced their price target on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. HSBC decreased their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Finally, DZ Bank started coverage on shares of Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.